Pablo Matar
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 17
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 12
- Toxin Mechanisms and Immunotoxins 3
- Biosimilars and Bioanalytical Methods 2
- Oncology 9
- CAR-T cell therapy research 2
- Co-authors
- Olga Graciela Scharovsky (18 shared papers)Viviana R. Rozados (13 shared papers)Silvia I. Gervasoni (10 shared papers)Marta Guzmán (2 shared papers)Joaquin Arribas (2 shared papers)José Baselga (2 shared papers)Federico Rojo (2 shared papers)María José Rico (5 shared papers)
- Journals
- Journal of Biomedical Science (3 papers)Cancer Immunology Immunotherapy (3 papers)OncoImmunology (2 papers)Generics and Biosimilars Initiative Journal (2 papers)Clinical & Experimental Metastasis (2 papers)
- Partner nations
- ArgentinaUnited StatesItaly
In The Last Decade
Pablo Matar
31 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 82
- Oncology 603
- Immunology 412
- Cancer Research 150
- Pulmonary and Respiratory Medicine 247
- Molecular Biology 414
Countries citing papers authored by Pablo Matar
This map shows the geographic impact of Pablo Matar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Matar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Matar more than expected).
Fields of papers citing papers by Pablo Matar
This network shows the impact of papers produced by Pablo Matar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Matar. The network helps show where Pablo Matar may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Matar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 247 | |
| 2 | ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. | 2003 | 223 |
| 3 | 2007 | 193 | |
| 4 | 2002 | 104 | |
| 5 | 2009 | 58 | |
| 6 | 2004 | 44 | |
| 7 | 2003 | 43 | |
| 8 | 2001 | 43 | |
| 9 | 1998 | 43 | |
| 10 | 1999 | 43 | |
| 11 | 2000 | 42 | |
| 12 | 2000 | 35 | |
| 13 | 2009 | 35 | |
| 14 | 2011 | 31 | |
| 15 | 2009 | 29 | |
| 16 | 2015 | 26 | |
| 17 | 2002 | 25 | |
| 18 | 2012 | 24 | |
| 19 | 2009 | 24 | |
| 20 | 1998 | 13 |
About Pablo Matar
Pablo Matar is a scholar working on Immunology, Oncology, Cancer Research, Hematology and Molecular Biology, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (12 papers), Hematopoietic Stem Cell Transplantation (5 papers), Cancer, Lipids, and Metabolism (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), CAR-T cell therapy research (2 papers), Lipoproteins and Cardiovascular Health (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Oncology (603 citations), Immunology (412 citations), Cancer Research (150 citations), Pulmonary and Respiratory Medicine (247 citations) and Molecular Biology (414 citations). Pablo Matar has collaborated with scholars based in Argentina, United States and Italy. Frequent co-authors include Olga Graciela Scharovsky, Viviana R. Rozados, Silvia I. Gervasoni, Marta Guzmán, Joaquin Arribas, José Baselga, Federico Rojo, María José Rico, Mariano F. Zacarías Fluck and Gabriel Adrian Rabinovich. Their work appears in journals such as Journal of Biomedical Science, Cancer Immunology Immunotherapy, OncoImmunology, Generics and Biosimilars Initiative Journal and Clinical & Experimental Metastasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.